Aveanna Healthcare Holdings, Inc. SEC Filings

Aveanna Healthcare Holdings Inc. announced a secondary offering by selling stockholders of 10,000,000 shares of common stock at $9.00 per share. The company will not receive any proceeds from these sales; proceeds go to the selling stockholders. Underwriters have a 30‑day option to purchase up to 1,500,000 additional shares.

The pricing implies an aggregate public offering of $90,000,000, with underwriting discounts of $4,050,000 and proceeds to selling stockholders of $85,950,000. Aveanna’s common stock trades on Nasdaq as AVAH. Shares outstanding were 208,259,393 as of June 28, 2025.

Aveanna also provided preliminary, unaudited Q3 results: revenue of $616–$624 million, net income of $11–$15 million, and Adjusted EBITDA of $77–$81 million, each described as growth over the prior year’s third quarter. Delivery of shares is expected on or about October 23, 2025.

Aveanna Healthcare Holdings (AVAH) announced a secondary offering in which the Selling Stockholders are offering 10,000,000 shares of common stock. The company stated it will not receive any proceeds from these sales. The underwriters have a 30‑day option to purchase up to 1,500,000 additional shares at the public offering price, less underwriting discounts and commissions.

The company included a preliminary third‑quarter update: revenue is expected at $616–$624 million (up 21.0%–22.6% year over year), net income at $11–$15 million (up 125.7%–135.0%), and Adjusted EBITDA at $77–$81 million (up 61.0%–69.3%). These figures are unaudited and subject to completion of financial closing procedures. A 90‑day lock‑up applies to the company, Selling Stockholders, directors and officers, subject to customary exceptions.

Shares outstanding were 208,911,373 as of October 15, 2025; this is a baseline figure, not the amount being offered.

Aveanna Healthcare Holdings Inc. furnished an 8-K to announce it issued a press release with preliminary results for the three-month period ended September 27, 2025. The press release, dated October 21, 2025, is included as Exhibit 99.1.

The company states the information under Item 2.02 is “furnished” and not “filed” under the Exchange Act, and will only be incorporated by reference into other filings if specifically stated.

Aveanna Healthcare Holdings Inc. Schedule 13G/A discloses significant ownership positions by several J.H. Whitney-related entities. J.H. Whitney VII, L.P. is reported as the beneficial owner of 28,890,755 shares (14.81%), and PSA Healthcare Investment Holdings LLC is reported as the beneficial owner of 15,588,583 shares (7.99%). Additional related entities report stakes of 1,443,143, 5,182,085, and 543,206 shares respectively.

The filing states the J.H. Whitney parties and Bain Capital-advised entities are bound by a Stockholders Agreement that requires them to vote for each other’s director nominees and coordinate transfers. The parties note that, based on available information, such a group could be deemed to beneficially own approximately 133,248,652 shares (≈68.302%), while the reporting persons disclaim beneficial ownership of each other’s shares and report sole voting and dispositive power over the shares they list.

On 8 Aug 2025 Aveanna Healthcare Holdings Inc. (AVAH) filed a Form 8-K under Item 7.01 (Regulation FD) to furnish an updated investor presentation (Exhibit 99.1). The deck is available in the “Investors” section of the company’s website and via IR e-mail alerts. Because the material is classified as “furnished,” it is not subject to Section 18 liability and will only be incorporated into other SEC filings if specifically referenced. Aveanna reiterates that its website is a primary channel for time-critical disclosures.

• No financial statements, earnings metrics or major transactions accompany this report.
• The 8-K is informational only and has no immediate accounting or voting impact.